• Site Search
  • Lawyer Search

Grant J. Esposito

Partner
New York, (212) 468-8166
  • Print PDF
  • Subscribe to RSS
  • MoFolder

Grant Esposito focuses his trial and arbitration practice on complex commercial litigation, including accountants’ liability, intellectual property, product liability, and securities law. Mr. Esposito has particular expertise in representing clients in the life sciences and professional-services industries in the United States, Canada, and Europe. A former Chair of Morrison & Foerster’s Litigation Department, he also advises on litigation management and business development issues.

Mr. Esposito’s work has been recognized in Chambers USA: Guide to America’s Leading Business Lawyers (New York–General Commercial Litigation), The Legal 500 US (Litigation–Product Liability, pharmaceuticals and medical devices), Best Lawyers in America (New York–Product Liability Litigation), and New York Super Lawyers (General Litigation).

Mr. Esposito received his B.A. in 1989 from Cornell University, and his J.D. in 1992 from Fordham University School of Law, where he was elected to the Order of the Coif. He is admitted to practice in the United States District Courts, Southern and Eastern Districts of New York, and the United States Courts of Appeal for the Second, Tenth, and Eleventh Circuits.

In re Sino-Forest Securities Litigation
Represent Canadian auditor in securities fraud proceedings in the U.S. and Canada. (2012-13)
In re Broadcom Corporation Class Action Litigation
(C.D.C.A.) Obtained favorable settlement in securities class action concerning allegations of options backdating. (2013)
Fownes Bros. v. JPMorgan Chase, et al.
(N.Y. Commercial Division and First Department) Won motion to dismiss and appeal of fraud action alleging negligent tax advice. (2012)
SP Syntax LLC v. Ernst & Young LLP, et al.
Following a three-week trial in California Superior Court, won a unanimous jury verdict on behalf of Ernst & Young, defeating claims that the accounting firm had made negligent representations in connection with financial statements issued by Syntax-Brillian. (2010)
Frontier Insurance Group, Inc. v. Ernst & Young LLP
Following a three-week trial in the Southern District of New York, won a unanimous jury verdict on behalf of Ernst & Young in an actuarial malpractice case seeking in excess of $200 million. (2009)
Anchor v. Novartis Grimsby Ltd., et al.
(W.D.N.Y.) Won motion to dismiss in a federal toxic tort case based on lack of personal jurisdiction, the Second Circuit affirmed. (2008)
Dulin, et al. v. Guidant, et al.
(W.D. K.Y.) Obtained dismissal for a large pharmaceutical company in a product liability case involving medical device where Plaintiff sought to confirm a class seeking medical monitoring. (2007)
IP Litigation
Represent generic arm of a major pharmaceuticals company in ANDA litigation throughout the United States. (2008-present)
In re UnitedHealth Group, Inc. Securities Litigation
(D. M.N.) Represented the former chair of the compensation committee of the board of directors of UnitedHealth Group Inc. in government investigations and civil actions relating to allegations of stock options backdating, resulting in avoidance of action by the government and favorable civil settlements. (2008)
Confidential Arbitrations
Numerous confidential proceedings involving breach of contract, purchase-price adjustment disputes, and professional malpractice.
Loading...
Loading...